Last reviewed · How we verify
1% Buffered Lidocaine 1:100,000 Epinephrine — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
1% Buffered Lidocaine 1:100,000 Epinephrine (1% Buffered Lidocaine 1:100,000 Epinephrine) — University of North Carolina, Chapel Hill.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 1% Buffered Lidocaine 1:100,000 Epinephrine TARGET | 1% Buffered Lidocaine 1:100,000 Epinephrine | University of North Carolina, Chapel Hill | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 1% Buffered Lidocaine 1:100,000 Epinephrine CI watch — RSS
- 1% Buffered Lidocaine 1:100,000 Epinephrine CI watch — Atom
- 1% Buffered Lidocaine 1:100,000 Epinephrine CI watch — JSON
- 1% Buffered Lidocaine 1:100,000 Epinephrine alone — RSS
Cite this brief
Drug Landscape (2026). 1% Buffered Lidocaine 1:100,000 Epinephrine — Competitive Intelligence Brief. https://druglandscape.com/ci/1-buffered-lidocaine-1-100-000-epinephrine. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab